Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Consensus Rating of “Buy” by Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has received a consensus rating of “Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and four have given a strong buy rating to the company.

Several equities analysts have issued reports on the stock. Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. HSBC raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday. JPMorgan Chase & Co. cut Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. Hsbc Global Res raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday. Finally, Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th.

View Our Latest Report on RBGLY

Reckitt Benckiser Group Price Performance

OTCMKTS:RBGLY opened at $12.26 on Friday. The stock’s 50-day moving average is $12.34 and its 200-day moving average is $11.74. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $15.03. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.